Source: International Congress 2017 – Imaging and lung disease PH
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tiwari (ALLAHABAD (UTTAR PRADESH), India). Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator. 2432

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Prognostic Factors for Mortality in Chronic Pulmonary Aspergillosis -Experience in Japan- Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Would RDW be a prognostic factor in pulmonary arterial hypertension? Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Exercise Pulmonary Vascular Resistances are Predictors of Survival in Systemic Sclerosis Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension Source: ERS Lung Science Conference 2021 Year: 2021 Clinical phenotypes in pulmonary emboli identified by cluster analysis Source: International Congress 2014 – Acute pulmonary embolism Year: 2014